4.8 Editorial Material

Opportunities and challenges using artificial intelligence in ADME/Tox

期刊

NATURE MATERIALS
卷 18, 期 5, 页码 418-422

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41563-019-0332-5

关键词

-

资金

  1. NCATS NIH HHS [R44 TR000942] Funding Source: Medline
  2. NIGMS NIH HHS [R44 GM122196] Funding Source: Medline
  3. NIH HHS [R44 GM122196-02A1] Funding Source: Medline

向作者/读者索取更多资源

At the recent Artificial Intelligence Applications in Biopharma Summit in Boston, USA, a panel of scientists from industry who work at the interface of machine learning and pharma discussed the diverging opinions on the past, present and future role of AI for ADME/Tox in drug discovery and development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据